alexa Single Nucleotide Polymorphisms (SNPs) In The Outcome Of Tacrolimus Treatment In Renal Transplantation | 17555
ISSN: 2161-0959

Journal of Nephrology & Therapeutics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference on Nephrology & Therapeutics
June 26-27, 2014 Valencia Conference Centre, Valencia, Spain

Mar?a Jos? Herrero
Accepted Abstracts: J Nephrol Ther
DOI: 10.4172/2161-0959.S1.016
Abstract
T he main goal of individualized medicine is optimizing the balance between therapeutic efficacy and the occurrence of adverse events, especially when employing narrow therapeutic index drugs such as immunosuppressants. These drugs are necessary for the transplanted patients. In this sense, pharmacogenetics can be very helpful to analyze this scenario and give a tool for helping the clinicians choose the right drug and the right dose for each patient. Changes in expression or function of proteins and enzymes involved in drug transport, metabolism or mechanism of action will cause changes in drug?s absorption, metabolism and distribution and, therefore, can lead to changes in the response and toxicity of the treatment. Characterization of these genetic variants, mainly Single Nucleotide Polymorphisms (SNPs), can help to establish effective doses and to minimize adverse effects. Many publications, including our own, have found statistically significant correlations between SNPs and tacrolimus dose-corrected blood levels. We will also be presenting our work correlating certain SNP variants with safety and efficacy of the treatment. All these findings are leading to the proposal of tacrolimus initial dose adjustments according to the recipient?s SNPs. Pharmacogenetic tests are becoming cheaper every day, so it is getting more assumable, especially when clinically relevant associated complications are demonstrated. Many results contribute to highlight the need of prospective controlled studies, with pharmacogenetic analysis prior to transplantation. Approaches to economic analyses will also be presented, in order to show the convenience of performing these tests, to save money and to improve the patients? health quality
Biography
Mar?a Jos? Herrero completed her PhD in Biology at University of Valencia. She has performed most of her research work in Gene Therapy. Her postdoctoral research has been focused at Hospital La Fe, in Valencia, addressed to the clinical application of Pharmacogenetics since 2008. She is now the head of laboratory of the Pharmacogenetics Unit at IIS La Fe, developing translational research in this field, in different clinical areas, ranging from Cancer to Transplantation, amongst others.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version